SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-042363
Filing Date
2017-02-14
Accepted
2017-02-14 11:18:03
Documents
2
Group Members
ANNE-MARI PASTERDANISH BIOTECH SPV I P/SDANISH BIOTECH SPV I, GP LTD.KRIS ALLENMARTIN MULLINSOMEGA FUND IV G.P. MANAGER, LTD.OMEGA FUND IV GP, L.P.OTELLO STAMPACCHIARICHARD LIM

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 2 d235448dsc13ga.htm SC 13G/A 193854
2 EX-99.1 d235448dex991.htm EX-99.1 9369
  Complete submission text file 0001193125-17-042363.txt   205025
Mailing Address 1 ROYAL PLAZA, ROYAL AVENUE ST. PETER PORT Y7 GY1 2HL
Business Address 1 ROYAL PLAZA, ROYAL AVENUE ST. PETER PORT Y7 GY1 2HL 44 0 148 173 5806
Omega Fund IV, L.P. (Filed by) CIK: 0001528382 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 600 LEE ROAD SUITE 100 WAYNE PA 19087
Business Address 600 LEE ROAD SUITE 100 WAYNE PA 19087 610-833-4200
Egalet Corp (Subject) CIK: 0001586105 (see all company filings)

IRS No.: 463575334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87969 | Film No.: 17604589
SIC: 2834 Pharmaceutical Preparations